Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

West Nile Virus Clinical Presentation and Management

Symptoms and Diagnosis

  • The Centers for Disease Control and Prevention recommends that patients with West Nile fever typically present with sudden onset of high fever, severe headache, generalized myalgias, and lumbosacral pain 1
  • The American Academy of Neurology suggests that serologic testing for virus-specific IgM and IgG antibodies in serum and/or CSF is a primary diagnostic method for West Nile virus infection 2
  • The Infectious Diseases Society of America indicates that IgM antibodies are detectable 3-8 days after symptom onset and typically decrease after 2-3 months 2
  • The Centers for Disease Control and Prevention notes that the presence of anti-WNV IgM in CSF indicates CNS infection 2

Laboratory Findings

  • The World Health Organization states that leukopenia may occur in the first week of illness, while leukocytosis may develop during the second week 1
  • The Centers for Disease Control and Prevention reports that bleeding abnormalities with elevated prothrombin and partial thromboplastin times, decreased platelet count, and presence of fibrin-split products may be observed in patients with West Nile virus infection 1

Treatment and Prevention

  • The Centers for Disease Control and Prevention recommends that personal protective measures, such as applying EPA-registered insect repellent to skin and clothing, wearing long-sleeved shirts and long pants, and avoiding outdoor activities during peak mosquito-feeding times, are essential for preventing West Nile virus infection 3
  • The American Academy of Neurology suggests that high-dose intravenous corticosteroids may be considered for acute disseminated encephalomyelitis associated with West Nile virus infection 3
  • The Infectious Diseases Society of America indicates that EEG should be considered in patients with undiagnosed encephalopathy to rule out non-convulsive status epilepticus 4